Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
Generics seek brands, Big pharma seek generics!
July 1, 2009
Lupin Expands Branded Play | www.sunherald.com
Generic companies have the creative R&D to develop value-added products and compete head-to-head with branded companies Branded companies see generics as an easy way to add products for their sales teams
January 21, 2009
Teva and Lonza Announce Strategic Partnership to Become a Leading Global Provider of Biosimilars | www.pipelinereview.com
I think it shows two important things: 1) Teva admit that they are not in the best position to manufacture 2) That Teva remove a potential manufacturing competitor from the market
January 20, 2009
Aurobindo Pharma gets approval for Terbinafine Tablets | myiris.com
The market is in decline, ALL major generic companies already have the product.. the only way for Aurobindo to get market share is to undercut the competition. With little margin already, not a money spinner.
All brawn and not enough brains
October 8, 2008
Pharma's new favorite outsourcing spot: China | www.fiercepharma.com
Yes the trend will continue, but with limitations, for now. China IS most definitely already a source for pharmaceutical manufacturing, but has a long way to go before becoming an independent creator of pharmaceutical intellectual property. Once it can, then outsourcing will really take off.
Page : 11 to 4 of 4
Mobile Advertising Set To Soar ? Yes, But What Is The Engine For Growth
November 17, 2009
Roche Receives H1N1 FDA Emergency Use Authorization
November 16, 2009
From a physician point of view
November 16, 2009
Zetia Now Off Best Practices List for MI Prevention, But is Niaspan > Diet?
November 15, 2009
November 15, 2009
www.medscape.com
Rapid DNA Test to Detect Clostridium difficile Infection Approved by FDA Today
www.medicalnewstoday.com
Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology
www.pipelinereview.com
www.nytimes.com
www.docguide.com
FDA: Ongoing Omalizumab Study Shows Increased Number of Cardiovascular Events